Drugs Health Pharma

Moldova green lights Precision BioSciences human trial for HBV

A clinical-stage US gene-editing company, Precision BioSciences, got approval from the Eastern European country of Moldova to start an in vivo human trial.

Read More
Drugs Health Pharma

US-based Tome Biosciences to retrench 131 employees 

Tome Biosciences, a US company engaged in gene editing, will lay off 131 employees as it plans to reduce costs, according to a.

Read More